1955
DOI: 10.1097/00000658-195502000-00006
|View full text |Cite
|
Sign up to set email alerts
|

Experiences With the Use of Radioactive Colloidal Gold in the Treatment of Cancer*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

1957
1957
2014
2014

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 9 publications
0
10
0
Order By: Relevance
“…The gamma emission that penetrated freely through the body became important for imaging. Produced colloidal gold nanoparticles were small enough (3-7 nm) [8] to pass through the pulmonary capillaries (<7 µm) but were accumulating mostly in the liver and spleen [9]. at higher dosages, even bone marrow could be visualized.…”
Section: Rise Of the Nuclear Imaging Techniques (1940s-1950s)mentioning
confidence: 99%
“…The gamma emission that penetrated freely through the body became important for imaging. Produced colloidal gold nanoparticles were small enough (3-7 nm) [8] to pass through the pulmonary capillaries (<7 µm) but were accumulating mostly in the liver and spleen [9]. at higher dosages, even bone marrow could be visualized.…”
Section: Rise Of the Nuclear Imaging Techniques (1940s-1950s)mentioning
confidence: 99%
“…A further 88 patients reported by Weisberger (1958) showed approximately the same percentage-64-to be improved, and again the most favourable response was obtained in patients with breast and ovarian tumours. In a series of 25 patients with bronchial carcinoma described by Bass (1960) five with malignant effusions were treated by the direct intrapleural injection of HN2, there being no reaccumulation of fluid up to the time of death in four.Many authors agree (King et al, 1952;Storaasli et al, 1953 ;Kent et al, 1954;Wheeler et al, 1955) that Au-198 can produce slowing down or cessation of malignant effusions in about 50-60% of patients, and that the best response is obtained where the primary tumour arises in the breast or ovary. Hilton et al (1957) reported the results of treatment with Au-198 of 94 patients at University College Hospital.…”
mentioning
confidence: 99%
“…Many authors agree (King et al, 1952;Storaasli et al, 1953 ;Kent et al, 1954;Wheeler et al, 1955) that Au-198 can produce slowing down or cessation of malignant effusions in about 50-60% of patients, and that the best response is obtained where the primary tumour arises in the breast or ovary. Hilton et al (1957) reported the results of treatment with patients at University College Hospital.…”
Section: Discussionmentioning
confidence: 99%